Abstract: The first object of the invention is primer sets for amplifying the nucleotide sequence of the L2 gene of human papillomavirus type 16 or L1 gene of human papillomavirus type 18. The second object of the invention is a method for detecting HPV16 or HPV18 viruses. Another object of the invention is a method of detecting HPV16 and HPV18 infections. A fourth object of the invention is a kit for detecting HPV16 or HPV18 infections.
Abstract: The first subject of the invention is a set of primers for amplifying nucleotide sequence of the Mycoplasma pneumoniae dnaE gene. The second subject of the invention is a method for detecting Mycoplasma pneumoniae bacteria. Another subject of the invention is a method for detecting an infection caused by the Mycoplasma pneumoniae bacterium. A fourth subject of the invention is a kit for detecting an infection caused by the Mycoplasma pneumoniae bacterium.
Abstract: The object of the invention is a method of detecting genetic material in a biological sample in which the biological sample is loaded into the reaction cartridge (6) and then the reaction cartridge (6) is placed in the control device, the collected biological sample is taken to the isolation chamber (7), isolation of biological material from the tested sample by heating the isolation chamber (7), the isolated genetic material is moved into a plurality of reaction chambers (8.1, 8.2, 8.3, 8.4), genetic material is amplified by heating the reaction chambers (8.1, 8.2, 8.3, 8.4), lyophilized reagents for genetic material amplification together with lyophilized fluorescent tag intercalating with genetic material are present in the reaction chambers (8.1, 8.2, 8.3, 8.4), and signal detection from fluorescent tags is carried out along with the genetic material amplification stage.
Type:
Grant
Filed:
August 25, 2020
Date of Patent:
March 21, 2023
Assignee:
Genomtec S.A.
Inventors:
Miron Tokarski, Henryk Waldemar Roguszczak
Abstract: The object of the invention is a method of detecting genetic material in a biological sample in which the biological sample is loaded into the reaction cartridge (6) and then the reaction cartridge (6) is placed in the control device, the collected biological sample is taken to the isolation chamber (7), isolation of biological material from the tested sample by heating the isolation chamber (7), the isolated genetic material is moved into a plurality of reaction chambers (8.1, 8.2, 8.3, 8.4), genetic material is amplified by heating the reaction chambers (8.1, 8.2, 8.3, 8.4), lyophilized reagents for genetic material amplification together with lyophilized fluorescent tag intercalating with genetic material are present in the reaction chambers (8.1, 8.2, 8.3, 8.4), and signal detection from fluorescent tags is carried out along with the genetic material amplification stage.
Type:
Grant
Filed:
December 21, 2017
Date of Patent:
September 22, 2020
Assignee:
GENOMTEC S.A.
Inventors:
Miron Tokarski, Henryk Waldemar Roguszczak